Cargando…

Combination Therapy for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Whom, When, and Where?

Detalles Bibliográficos
Autores principales:	Siedner, Mark J., Campbell, Jeffrey I., Kanters, Steve, Bennett, John E., Thorlund, Kristian, Tsai, Alexander C., Mills, Edward J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462891/ https://www.ncbi.nlm.nih.gov/pubmed/26125034 http://dx.doi.org/10.1093/ofid/ofv071

Ejemplares similares

Comparative Effectiveness of Induction Therapy for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: A Network Meta-Analysis
por: Campbell, Jeffrey I., et al.
Publicado: (2015)

Venous Sinus Dysplasia Masking the Diagnosis of Cryptococcal Meningitis
por: Zheng, Qian, et al.
Publicado: (2016)

Extracorporeal membrane oxygenation support in patients with hematologic malignancies: to whom and when?
por: Hong, Junshik, et al.
Publicado: (2017)

Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and Outcomes
por: Pastick, Katelyn A, et al.
Publicado: (2019)

To Whom It May Concern
por: Butler, C. B., et al.
Publicado: (1869)

Cryptococcal meningitis in a human immunodeficiency virus negative patient with follicular lymphoma
por: Nandennavar, Manjunath, et al.
Publicado: (2014)

Cryptococcal meningitis in a human immunodeficiency virus-negative patient with rheumatoid arthritis
por: Haghighi, Samaneh, et al.
Publicado: (2016)

Surgical treatment and operation time in human immunodeficiency virus-negative cryptococcal meningitis
por: Zhao, Jie, et al.
Publicado: (2020)

Honor to Whom Honor Is Due
Publicado: (1872)

When Doctors Differ Where Is Safety?
Publicado: (1871)

Use of network meta-analysis in clinical guidelines
por: Kanters, Steve, et al.
Publicado: (2016)

When does the use of individual patient data in network meta-analysis make a difference? A simulation study
por: Kanters, Steve, et al.
Publicado: (2021)

Where, when, and to whom gaming motives may be harmful? A systematic review
por: Amudhan, Senthil, et al.
Publicado: (2022)

Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?
por: Ngan, Nguyen Thi Thuy, et al.
Publicado: (2022)

Cryptococcal Meningitis in Patients with or without Human Immunodeficiency Virus: Experience in a Tertiary Hospital
por: Lee, Su Jin, et al.
Publicado: (2011)

Acute Kidney Injury and Urinary Biomarkers in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis
por: Schutz, Charlotte, et al.
Publicado: (2017)

Exploring the context of sedentary behaviour in older adults (what, where, why, when and with whom)
por: Leask, Calum F., et al.
Publicado: (2015)

The assistance gaps in combating COVID-19 in Brazil: for whom, where and when vaccination occurs
por: Moreira, Rafael da Silveira, et al.
Publicado: (2022)

Molecular mechanisms of cryptococcal meningitis
por: Liu, Tong-Bao, et al.
Publicado: (2012)

Cryptococcal meningitis complicating sarcoidosis
por: Leonhard, Sonja E., et al.
Publicado: (2016)

Midwifery continuity of care: A scoping review of where, how, by whom and for whom?
por: Bradford, Billie F., et al.
Publicado: (2022)

Cryptococcal meningitis: epidemiology and therapeutic options
por: Sloan, Derek J, et al.
Publicado: (2014)

Use of the Correlation Coefficient to Compare a Point-of-Care Antigen Test Against a Quantitative Sandwich Enzyme-Linked Immunosorbent Assay for the Detection of Cryptococcal Meningitis
por: Lee, Sue J., et al.
Publicado: (2012)

Neuroimaging of Cryptococcal Meningitis in Patients without Human Immunodeficiency Virus: Data from a Multi-Center Cohort Study
por: Anjum, Seher H., et al.
Publicado: (2023)

Immunodeficiency Should Be Excluded in Patients With Recurrent Viral Meningitis and Breakthrough COVID-19
por: Finsterer, Josef
Publicado: (2022)

The effects of excluding treatments from network meta-analyses: survey
por: Mills, Edward J, et al.
Publicado: (2013)

When, where, and with whom during crisis: The effect of risk perceptions and psychological distance on travel intentions
por: Fuchs, Galia, et al.
Publicado: (2024)

Rheumatoid vasculitis mimicking cryptococcal infection
por: Iinuma, Shin, et al.
Publicado: (2021)

Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?
por: Kagimu, Enock, et al.
Publicado: (2022)

Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis
por: Mpoza, Edward, et al.
Publicado: (2017)

PSA screening – for whom and when?
por: Albers, Peter
Publicado: (2019)

Bempedoic Acid: for Whom and When
por: Ruscica, Massimiliano, et al.
Publicado: (2022)

Hearing Loss in Cryptococcal Meningitis Survivors
por: Lofgren, Sarah, et al.
Publicado: (2017)

Treatment for HIV‐associated cryptococcal meningitis
por: Tenforde, Mark W, et al.
Publicado: (2018)

Cryptococcal meningitis: A neglected NTD?
por: Molloy, Síle F., et al.
Publicado: (2017)

Cryptococcal Meningitis in an Apparent Immunocompetent Patient
por: Poley, Marian, et al.
Publicado: (2019)

Microglia are not protective against cryptococcal meningitis
por: Mohamed, Sally H., et al.
Publicado: (2023)

Cryptococcal Meningitis in an Apparent Immunocompetent Host
por: Molina, Guarina, et al.
Publicado: (2023)

Connecting Cryptococcal Meningitis and Gut Microbiome
por: Ma, Yuanyuan, et al.
Publicado: (2023)

A Rare Presentation of Cryptococcal Meningitis and Cerebellitis in an Asplenic Patient, Seronegative for Human Immunodeficiency Virus (HIV)
por: Abbas, Hafsa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v5vv8ctr3sib08ea6qve21si6m